The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
Shocking revelations from a Federal Trade Commission, or FTC, investigation have exposed how three major prescription benefit managers, or PBMs, ...
The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...
UnitedHealth, the biggest insurance company in America, is receiving backlash after an FTC report revealed that it was ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.